Improving Memory for Sleep Treatment Content With Text Messages

Status Completed

Clinical Trial Summary

A drop off in improvement over the months and years after treatment is common. One contributor may be poor memory for the contents of treatment. This study seeks to determine whether text messages containing reminders of the content of sessions will improve treatment outcomes.

Clinical Trial Description

The growth in the use of technology provides an opportunity to send reminders to participants via text messages. The early studies on text messaging interventions indicate this approach is enjoyable for participants and has positive effects across a range of domains and treatment types. Hence, this study will test whether text messages containing reminders of the content of sessions will improve treatment outcomes. Two text messaging methods will also be tested. One is to send text messages to remind participants of their goals (PUSH condition) and the second is to send text messages to remind participants to recall their goals (PULL condition). This study will be conducted within the context of an NICHD-funded Randomized Controlled Trial (grant number R01-HD071065; protocol registration ID NCT01828320). In R01-HD071065 adolescents ages 10-18 (n = 176) will receive either the Transdiagnostic Sleep and Circadian Intervention (TranS-C) or a Psychoeducation (PE). At the 6-month follow-up assessment for R01-HD071065, participants will be randomized using 3 (PUSH text messages, PULL text messages, or no text messages) x 2 (TranS-C or PE) design. At the 6-month follow-up assessment, a questionnaire will also be administered to establish baseline memory for treatment. Participants will be sent text messages once per week until they return for the 12 month follow-up assessment for R01-HD071065. At the 12 month follow-up assessment, participants will be asked to complete the same memory for treatment questionnaire completed at the 6 month follow-up assessment as well as a questionnaire evaluating the acceptability of the text message reminders. This research is a first step toward identifying whether an inexpensive and ubiquitous technology (i.e., text messaging) can improve memory for treatment. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02961400
Study type	Interventional
Source	University of California, Berkeley
Contact
Status	Completed
Phase	N/A
Start date	October 2013
Completion date	December 2018

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03852966` - Better Sleep in Psychiatric Care - ADHD Pilot Study	N/A
Completed	`NCT04990206` - Improving Sleep Health in Adults With Overweight or Obesity	N/A
Recruiting	`NCT06242717` - Postpartum Screening for Anxiety and Comorbid Conditions
Completed	`NCT04200495` - PSG Validation Study of Zensorium Biosensing Wearable Device
Recruiting	`NCT04690504` - Validation of Circadian Biomarkers in Patients With Sleep Disorders
Recruiting	`NCT04729478` - Comparison Between Natural Sleep Endoscopy and Drug-induced Sleep Endoscopy in Patients With Obstructive Sleep Apnea	N/A
Recruiting	`NCT05012605` - The SLEEPR Study: SLEep Effects on Post-stroke Rehabilitation
Completed	`NCT04451668` - An Open Label Study of FT218 in Subjects With Narcolepsy	Phase 3
Recruiting	`NCT03956745` - Biomarkers for Circadian Timing in Healthy Adults
Completed	`NCT06440226` - Testing Methods to Increase the Frequency of Lucid Dreaming
Recruiting	`NCT05971212` - Sleep Support for Children With Neurodevelopmental Disorders	N/A
Withdrawn	`NCT04506112` - Optimizing Cardiac Rehabilitation by Integrating Sleep Therapeutics	N/A
Completed	`NCT03130803` - Biomarkers of Insufficient Sleep and Sleepiness	N/A
Recruiting	`NCT05565833` - Sleep Healthy Using the Internet Mitigating Insomnia to Address Neurocognitive Difficulties (SHUTi MIND)	Phase 2
Recruiting	`NCT04652882` - Evaluating the Effects of Tasimelteon vs. Placebo in Delayed Sleep-Wake Phase Disorder (DSWPD)	Phase 3
Recruiting	`NCT04214184` - Biomarkers of Increased Free Living Sleep Time	N/A
Active, not recruiting	`NCT03617497` - Prevalence of Epilepsy and Sleep Wake Disorders in Alzheimer Disease	N/A
Completed	`NCT03576664` - Effects of Sleep Deprivation and Adrenergic Inhibition on Glymphatic Flow in Humans	Early Phase 1
Completed	`NCT02922439` - Health Literacy Assessment and Intervention to Reduce Disparities: FLIGHT/VIDAS II	N/A
Completed	`NCT05568381` - Sleep Disturbance in MCI: A Study of a Cognitive Behavioural Therapy Digital Intervention	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.